組換え型ヒトインターフェロンIFN-α2とIFN-ω1の抗ウイルス活性
スポンサーリンク
概要
- 論文の詳細を見る
The interferons (IFN) were discovered in 1957 as biological agents interfering with viral replication. IFNs were initially classified according to their sources as leukocyte, fibroblast and immune IFNs. Both leukocyte and fibroblast IFNs are designated as Type I IFNs and immune IFN as a Type II IFN. There are almost twenty related IFNs which belong to the group of Type I IFN. IFN-α2 and IFN-ω1 are described as members of the large group of Type I IFN. Both natural IFN-α2 and IFN-ω1 are isolated from human leukocytes. IFN-α2 carries an O-linked carbohydrate moiety, whereas IFN-ω1 has an N-linked complex oligosaccharide. Recombinant IFN-α2 expressed in E coli. and Sf-9 cells have been characterized. Moreover, recombinant IFN-ω1 expressed in CHO cells and Sf-9 cells have also been characterized. In the present study, the recombinant human IFN-α2 and IFN-ω1 were analyzed for their anti-viral activity compared with native products.
- 公益社団法人日本薬学会の論文
- 1995-05-25
著者
-
杉山 憲司
日本ベーリンガーインゲルハイム(株)川西医薬研究所 分子生物学研究部
-
Voss Tilman
ベーリンガーインゲルハイム ベンダー社 蛋白工学研究部
-
AHORN Horst
ベーリンガーインゲルハイム ベンダー社 蛋白工学研究部
-
MAURER FOGY
ベーリンガーインゲルハイム ベンダー社 蛋白工学研究部
-
BARSOUMIAN Edward
日本ベーリンガーインゲルハイム(株)川西医薬研究所 分子生物学研究部